LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, announces that at the Special Meeting held earlier today, both resolutions put to Stockholders were duly passed. The proxy votes cast in respect of the Resolutions are as follows: No. Summary of Resolution For* % Against % Withheld** 1 To authorise, in […]
1. Issuer Details ISIN USU5500L1045 Issuer Name LungLife AI, Inc. UK or Non-UK Issuer Non-UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Cable Car Capital LLC City of registered office (if applicable) San Francisco Country of registered office (if applicable) United […]
LungLife AI licensure/accreditation information posted here.